Sub-chronic copper pretreatment reduces oxidative damage in an experimental Huntington's disease model.

Martínez-Lazcano, Juan Carlos; Montes, Sergio; Sánchez-Mendoza, María Alicia; Rodríguez-Páez, Lorena; Pérez-Neri, Iván; Boll, Marie Catherine; Campos-Arroyo, Hortensia Denise; Ríos, Camilo; Pérez-Severiano, Francisca

Martínez-Lazcano, Juan Carlos; Montes, Sergio; Sánchez-Mendoza, María Alicia; Rodríguez-Páez, Lorena; Pérez-Neri, Iván; Boll, Marie Catherine; Campos-Arroyo, Hortensia Denise; Ríos, Camilo; Pérez-Severiano, Francisca.

Affiliation

Martínez-Lazcano JC; Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Insurgentes Sur #3877, Col. La Fama, Del. Tlalpan, 14269, D.F., Mexico City, Mexico.

Biol Trace Elem Res ; 162(1-3): 211-8, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25319005

Subject(s)

Copper/therapeutic use; Huntington Disease/drug therapy; Huntington Disease/metabolism; Animals; Apomorphine/toxicity; Copper/pharmacology; Disease Models, Animal; Huntington Disease/chemically induced; Lipid Peroxidation/drug effects; Male; Oxidative Stress/drug effects; Quinolinic Acid/toxicity; Rats; Rats, Wistar; Reactive Oxygen Species/metabolism; Superoxide Dismutase/metabolism; gamma-Aminobutyric Acid/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Huntington Disease / Copper Type of study: Prognostic_studies Language: En Journal: Biol Trace Elem Res Year: 2014 Type: Article Affiliation country: Mexico

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google